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as “drain output of any measurable volume 
of fluid on or after postoperative day 3 with 
an amylase content greater than three times 
the serum amylase activity” [11].
The overall rate of pancreatic fistula after 
pancreaticoduodenectomy ranges from 17% 
in patients in whom the pancreatic remnant 
has a hard consistency [12] and exocrine pan-
creatic function and pancreatic juice output 
are impaired [13] to 25% in cases in which 
the pancreas is soft [1], that is, the parenchy-
ma is normal [13]. Soft pancreatic texture [1, 
3, 13] and small pancreatic duct size [3] are 
the most important preoperative risk factors 
for the development of pancreatic fistula.
The diagnosis of pancreatic fistula usually 
is made an average of 7 days after pancreati-
coduodenectomy [5, 14, 15]. Pancreatic fistula 
diagnosed with repeated assays of pancreatic 
enzymes in peripancreatic fluid drainage [11, 
14, 16] is recognized in only 70–75% of cases 
[2, 5, 17]. The peripancreatic drains routinely 
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ancreaticoduodenectomy is safe 
in the management of various 
malignant and benign diseases 
of the pancreatic head and peri-
ampullary region. Although the mortality 
rate has decreased to approximately 1–2% at 
high-volume centers, the morbidity rate rang-
es from 30% to 50% [1–4]. The two most 
frequent complications of pancreaticoduo-
denectomy are delayed gastric emptying and 
pancreatic fistula.
Pancreatic fistula after pancreaticoduo-
denectomy is a serious complication result-
ing in prolonged hospital stay, increased 
costs, readmission, and a mortality rate of 
3–9% [5, 6]. Efforts to reduce the incidence 
of pancreatic fistula have included definition 
of risk factors [1, 7], improvement of surgical 
technique [8, 9], and perioperative adminis-
tration of somatostatin and its analogues [1, 
10]. The International Study Group on Pan-
creatic Fistula has defined pancreatic fistula 
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OBJECTIVE. The purpose of this study was to evaluate the sensitivity and specificity of 
routine performance of CT on postoperative day 7 in patients at high risk of pancreatic fistula 
after pancreaticoduodenectomy.
MATERIALS AND METHODS. Two radiologists analyzed images from CT examina-
tions of 50 patients with soft pancreas 7 days after pancreaticoduodenectomy. Pancreatic fistu-
la was defined at CT as a fluid collection close to the pancreaticogastric or pancreaticojejunal 
anastomosis. Clinicobiologic criteria for the diagnosis of pancreatic fistula were drain output 
of any measurable volume of fluid on or after postoperative day 3 that had an amylase content 
more than three times the serum amylase activity. The final diagnosis of pancreatic fistula was 
rendered on the basis of clinicobiologic data at hospital discharge or at first readmission.
RESULTS. At hospital discharge or at first readmission, 27 of 50 patients (54%) had a 
pancreatic fistula. On postoperative day 7, 30 patients (60%) had a total of 51 fluid collections, 
and CT showed a fluid collection close to the pancreaticogastric or pancreaticojejunal anasto-
mosis in 21 of 51 cases. CT had a sensitivity of 63% (17/27 patients) and a specificity of 83% 
(19/23 patients) for the diagnosis of pancreatic fistula with four false-positive and 10 false-
negative findings. The diagnosis of pancreatic fistula on the basis of clinicobiologic criteria 
on postoperative day 7 was made in 22 of 27 patients (81%), whereas five cases were false-
negative. Four of these patients had CT evidence of pancreatic fistula.
CONCLUSION. In patients at high risk who have undergone pancreaticoduodenectomy, 
systematic postoperative CT may be proposed as a complementary tool in the diagnosis of 
pancreatic fistula, particularly for detection of clinically occult pancreatic fistula.
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inserted at the end of pancreaticoduodenec-
tomy by almost all surgeons [18] do not pre-
vent development of complications related to 
pancreatic fistula, such as the collections and 
abscesses found in 10–40% of patients [8, 
19–21]. Moreover, 5–9% of patients need re-
admission for fistula or abscess because pan-
creatic fistula was not diagnosed in the im-
mediately postoperative period [18, 20, 22]. 
Decreasing the rate of occult or delayed pan-
creatic fistula should be a reasonable goal.
The proper role of CT in the diagnosis of 
pancreatic fistula after pancreaticoduodenec-
tomy remains controversial. Although some 
authors [2, 3] routinely perform postoperative 
CT and include CT in the criteria for pancre-
atic fistula diagnosis, others [17] do not rec-
ommend CT in the diagnosis of pancreatic 
fistula because of the high prevalence of tran-
sient intraabdominal fluid collections after 
pancreaticoduodenectomy [22]. In an effort to 
clarify the role of CT in the diagnosis of pan-
creatic fistula after pancreaticoduodenectomy, 
we evaluated the sensitivity and specificity of 
routine CT on postoperative day 7 in patients 
at high risk of pancreatic fistula.
Materials and Methods
Institutional review board approval was ob-
tained for review of the patients’ medical records. 
Before undergoing CT, all patients provided writ-
ten informed consent to allow use of their CT data 
for research purposes.
Inclusion Criteria
Patients were included in the study if they had 
undergone pancreaticoduodenectomy for benign 
or malignant disease of the pancreatic head and 
distal biliary tract during the 4-year study peri-
od, had a soft pancreas, and had undergone ab-
dominal CT on postoperative day 7. Soft pancreas 
was defined histologically as the absence of fibro-
sis or the presence of slight fibrosis of the pancre-
atic stump, that is, grade 0 on the 0–3 scale of the 
Klöppel and Maillet classification [23].
During the study period, 144 pancreaticoduo-
denectomies were performed at our hospital. In 62 
of the patients, the pancreas had a soft consisten-
cy as assessed intraoperatively by the surgeon. All 
of these patients underwent CT on postoperative 
day 7, as is routine at our institution for all patients 
with soft pancreas because of the higher risk of de-
velopment of postoperative fistula than among pa-
tients with a fibrotic pancreas. When perianasto-
motic collections were detected on postoperative 
day 7, follow-up CT was performed weekly until 
resolution occurred. Seven patients were excluded 
from the study because fibrosis on the transection 
margin of the pancreas (Klöppel and Maillet grade 
1–3) was detected at histologic examination. Five 
patients were excluded because CT images could 
not be located. Therefore, the final study group 
consisted of 50 patients (23 men, 27 women; mean 
age, 58 years; range, 18–82 years).
Surgical Technique
All patients underwent standard pancreaticodu-
odenectomy. Reconstruction was by end-to-side 
pancreaticogastrostomy in 48 of 50 cases (96%) 
and by end-to-end pancreaticojejunostomy in two 
cases (4%). Multichannel open passive silicone 
drains were placed close to the biliary and pan-
creaticogastric or pancreaticojejunal anastomo-
ses and pulled out through the right or left flank. 
Surgical drainage output was collected daily, and 
biochemical amylase level and results of bacterio-
logic analysis were recorded on days 1, 3, 5, 7, and 
10. Serum amylase level was measured on post-
operative days 1, 3, 5, 7, and 10. All patients had 
a nasogastric tube for gastric decompression un-
til return of bowel activity and received octreotide 
during the 7 postoperative days for prophylaxis of 
pancreatic fistula [10]. In the absence of clinical 
or biochemical evidence of pancreatic fistula, oral 
feeding was allowed on postoperative day 7, and 
the surgical drain was progressively removed.
Histologic Analysis
Histologic analysis of resected specimens 
showed 14 cases of pancreatic adenocarcinoma 
(28%); 10 of intraductal papillary mucinous neo-
plasm (20%), one of which had malignant trans-
formation; eight of ampullary adenocarcinoma 
(16%); six of distal common bile duct carcinoma 
(12%); and five cases of endocrine tumor (10%). 
Less common findings were three cases of solid 
pseudopapillary tumor (6%), one case of pseudo-
tumoral cholangitis (2%), one of mass-forming 
pancreatic tuberculosis (2%), one of duodenal 
stromal tumor (2%), and one case of duodenal ad-
enocarcinoma (2%).
Definition of Pancreatic Fistula
Pancreatic fistula was defined as the presence 
of at least one of the two following criteria: first, 
drain output of any measurable volume of fluid on 
or after postoperative day 3 that had an amylase 
content greater than three times the serum amy-
lase activity [11] and, second, anastomotic leakage 
confirmed at reoperation or percutaneous drain-
age for major complications, such as abdominal 
bleeding and sepsis, during the hospital stay or 
first readmission [1, 8, 20, 22]. First readmission 
was defined as the first hospitalization for a com-
plication of the initial pancreaticoduodenectomy 
within 3 months after hospital discharge [24]. The 
final diagnosis of pancreatic fistula was defined on 
the basis of the clinical and biochemical data dur-
ing the hospital stay or at first readmission.
Imaging Protocol
Before and after IV contrast administration, 
CT was performed with an MDCT scanner (Light-
Speed Ultra, GE Healthcare) with a 0.5-second 
tube rotation time and acquisition of eight slices 
per rotation. No oral contrast material was admin-
istered. Unenhanced CT was performed at 5-mm 
section thickness and 5-mm intervals, 35-cm field 
of view, high-speed mode, 15.0 mm/rotation, 120 
kVp, and 200 mA. Nonionic iodinated contrast 
material (2 mL/kg iobitridol, Xenetix 350, Guer-
bet) was administered with a power injector (MCT, 
Medrad) through an 18- to 20-gauge angiographic 
catheter in an antecubital vein at a flow rate of 4–5 
mL/s. Acquisition was begun 70 seconds after the 
start of contrast injection at 5-mm section thick-
ness and 5-mm intervals, field of view to fit, high-
quality mode, 7.5 mm/rotation, 120 kVp, and 200 
mA. Images were obtained in the craniocaudal di-
rection in all phases. Patients with abnormal bio-
chemical or imaging findings underwent weekly 
(day 14, day 21, and so on) follow-up CT.
Image Analysis
Two experienced abdominal radiologists (17 and 
5 years of experience) in consensus retrospective-
ly analyzed the hard-copy CT images. Both radi-
ologists knew the indication for surgery and type 
of resection, but they were not aware of the clinical 
and biochemical findings on postoperative day 7 or 
the final diagnosis of pancreatic fistula. For each pa-
tient, the two radiologists determined the presence 
(number and location) and imaging features (shape, 
size, attenuation, homogeneity, wall enhancement) 
of intraabdominal and retroperitoneal fluid collec-
tions on postoperative day 7. Fluid collections were 
classified into peripancreatic collections (close, that 
is, immediately adjacent, to the pancreaticogastric 
or pancreaticojejunal anastomosis) and other col-
lections, according to site (superior recess of lesser 
sac, subhepatic space, right and left paracolic gut-
ters, root of mesentery) [25]. The presence of air 
bubbles was recorded for each fluid collection. The 
radiologists considered any fluid collection adja-
cent to the pancreaticogastric or pancreaticojeju-
nal anastomosis a pancreatic fistula [26].
The following postoperative changes and com-
plications also were analyzed: findings of acute 
pancreatitis of the pancreatic remnant (pancreat-
ic necrosis, infiltration of adipose peripancreatic 
tissue or thickening of the right and left parare-
nal fascia); normal caliber (< 3 mm) or dilatation 
of the pancreatic duct; infiltration of the adipose 
perivascular tissue surrounding the celiac trunk, 
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superior mesenteric vessels, and hepatic vessels 
(perivascular cuffing); abnormal abdominal and 
retroperitoneal lymph nodes, indicated by a short 
axis longer than 1 cm; vascular involvement, such 
as main or intrahepatic portal venous thrombo-
sis, hepatic or mesenteric venous thrombosis, and 
formation of pseudoaneurysms; hepatic or bil-
iary abnormalities or pneumobilia; ascites, pneu-
moperitoneum, and periportal lymphedema; and 
extra abdominal complications, such as pleural ef-
fusion and atelectasia.
To correlate the results of the image analysis 
with the final diagnosis of pancreatic fistula at 
hospital discharge or at first readmission, the two 
radiologists retrospectively reviewed the clinico-
biologic findings in all cases in which a false-posi-
tive or a false-negative diagnosis of pancreatic fis-
tula had been made to determine the cause of the 
incorrect CT diagnosis.
Statistical Analysis
Data are presented as mean ± SD. Categoric 
variables were compared by use of the Fisher’s 
exact test. A value of p < 0.05 was considered to 
indicate a statistically significant difference. Sen-
sitivity and specificity for the diagnosis of pancre-
atic fistula with clinicobiologic data and CT find-
ings were calculated.
Results
Pancreatic Fistula and CT Findings
At hospital discharge, 27 of the 50 patients 
(54%) had a definitive diagnosis of pancreat-
ic fistula. For 25 patients, the diagnosis was 
based on clinical and biologic data; for one, 
it was made at reoperation for abdominal 
bleeding; and for one patient, the diagnosis 
was based on the elevated level of amylase in 
aspirate percutaneously obtained from a pe-
rianastomotic collection. No patient needed 
readmission for pancreatic fistula or major 
complications after hospital discharge.
At CT 7 days after pancreaticoduodenec-
tomy, 20 patients had no intraabdominal flu-
id collections, but 30 patients (60%) had a 
total of 51 fluid collections. Sixteen of the 
50 patients (32%) had one collection (Figs. 
1 and 2), seven (14%) had two collections 
(Fig. 3), and seven (14%) had three or more 
collections. Fluid collections were close to 
the pancreaticogastric or pancreaticojeju-
nal anastomosis (Figs. 1–3) in 21 of 51 cas-
es (41%). These perianastomotic collections 
were round in six of 21 cases (29%), oval in 
nine of 21 cases (43%), and of various mor-
phologic configurations in six of 21 cases 
(29%). The mean long axis of these perian-
astomotic collections was 4.1 ± 4.9 cm, and 
the mean short axis was 1.6 ± 0.7 cm. All 
these collections had fluid attenuation and 
homogeneous content. At CT, increased at-
tenuation, as typically observed in hemato-
mas, was never seen within the collections. 
Wall enhancement was seen in four of 21 
perianastomotic collections (19%). Air bub-
bles were seen in six of 51 collections (12%), 
five of which were perianastomotic (five of 
21, 24%).
The presence of a fluid collection close 
to the pancreaticogastric or pancreaticoje-
junal anastomosis was considered diagnos-
tic of pancreatic fistula, and CT performed 
on postoperative day 7 depicted a pancreat-
ic fistula in 21 patients (Figs. 1 and 2). CT 
had a sensitivity of 63% (17 of 27 patients) 
and a specificity of 83% (19 of 23 patients). 
Therefore, there were four false-positive di-
agnoses (Fig. 4) and 10 false-negative diag-
noses (Fig. 5).
False-positive perianastomotic collections 
were small, having a mean diameter of 3.8 ± 
0.7 × 1.8 ± 0.6 cm. Two of four false-positive 
perianastomotic collections (50%) had a long 
axis measuring 2 cm or less, but only four of 
17 true-positive perianastomotic collections 
(24%) had a long axis measuring 2 cm or 
less. These results were not statistically sig-
nificant (p > 0.05). No false-positive collec-
tions contained air bubbles. In the 10 false-
negative cases at CT, retrospective analysis of 
the CT images showed that the drainage tube 
always had been placed immediately adja-
cent to the pancreaticogastric or pancreati-
cojejunal anastomosis.
On postoperative day 14, true-positive pe-
rianastomotic collections were found in 14 of 
17 patients (82%). Fluid collections had en-
larged in four patients and were the same size 
as at the previous examination in 10 patients. 
Fig. 1—62-year-old woman 7 days after 
pancreaticoduodenectomy for duodenal stromal 
tumor. Transverse contrast-enhanced helical 
CT scan of abdomen shows perianastomotic 
fluid collection measuring maximum of 10 × 1 cm 
close to anastomosis (open arrow), containing air 
bubbles (arrow), and exhibiting wall enhancement 
(arrowheads). Pancreatic remnant has normal 
enhancement without signs of postoperative 
pancreatitis or dilatation of pancreatic duct. 
Clinicobiologic diagnosis was pancreatic fistula on 
postoperative day 7. Both radiologists made correct 
diagnosis.
Fig. 2—54-year-old woman 7 days after 
pancreaticoduodenectomy for pancreatic 
adenocarcinoma. Transverse contrast-enhanced 
helical CT scan of abdomen shows perianastomotic 
fluid collection close to anastomosis (open arrow) 
and containing air bubbles (white arrowheads). 
Drain (black arrowhead) is next to anastomosis. 
Black arrow indicates perivascular cuffing 
surrounding superior mesenteric vessels. Patient 
had clinicobiologic diagnosis of pancreatic fistula on 
postoperative day 7. Both radiologists made correct 
diagnosis.
Fig. 3—62-year-old man 7 days after 
pancreaticoduodenectomy for pancreatic 
adenocarcinoma. Transverse contrast-enhanced 
helical CT scan of abdomen shows perianastomotic 
fluid collection (open arrow) close to anastomosis 
and containing small air bubbles (arrowheads). Solid 
arrow indicates another collection in posterior 
compartment of superior recess of lesser sac. 
Drainage tube (not shown) was displaced far from 
anastomosis in abdominal cavity. On postoperative 
day 7 patient had no clinicobiologic findings of 
pancreatic fistula, but both radiologists made correct 
diagnosis of pancreatic fistula (occult pancreatic 
fistula). During hospital stay, amylase level became 
elevated; therefore, patient had diagnosis of 
pancreatic fistula at hospital discharge.
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Three of 17 patients (18%) no longer had col-
lections on postoperative day 14. All false-
positive perianastomotic collections had dis-
appeared at follow-up: three of four (75%) by 
postoperative day 14 and one of four (25%) 
by postoperative day 21.
On postoperative day 7, pancreatic fistu-
las in 22 of the 50 patients (44%) were di-
agnosed on the basis of clinicobiologic data 
alone. The clinicobiologic criteria for the di-
agnosis of pancreatic fistula on postoperative 
day 7 had a sensitivity of 81% (22 of 27 pa-
tients). In this subgroup of patients, a perian-
astomotic fluid collection was seen at CT in 
13 of 22 patients (59%). Five patients without 
criteria for diagnosis of pancreatic fistula at 
postoperative day 7 were diagnosed as hav-
ing a pancreatic fistula during their hospi-
tal stay. CT depicted a perianastomotic fluid 
collection in four of the five patients (80%).
Other CT Findings on Postoperative Day 7
The 30 nonperianastomotic fluid collec-
tions were found in the anterior compartment 
of the superior recess of the lesser sac in 11 
of 51 cases (22%), in the posterior compart-
ment of the superior recess of the lesser sac 
in six of 51 cases (12%), and in other loca-
tions in 13 of 51 cases (25%). No collection 
was found close to the hepaticojejunostomy 
or gastrojejunostomy.
All patients had a normal pancreatic rem-
nant with homogeneous parenchymal en-
hancement and no infiltration of adipose 
peripancreatic tissue. We detected thicken-
ing of the left pararenal fascia in seven cas-
es (14%) and thickening of the right parare-
nal fascia in one case (2%). None of these 
patients had clinical or biologic findings of 
acute pancreatitis.
The pancreatic duct was of normal caliber 
(< 3 mm) in most patients (47 of 50, 94%). 
Minimal dilatation (< 5 mm) was found in 
three of 50 patients (6%). Mesenteric or he-
patic perivascular cuffing was present in 14 
of 50 patients (28%). Retroperitoneal or ce-
liacomesenteric lymph nodes larger than 1 
cm in the short axis were found in three of 
50 patients (6%). No abdominal bleeding 
or pseudoaneurysms were seen. The main 
portal vein, hepatic veins, and mesenteric 
vein were patent in all cases. An infarct in 
the right lobe of the liver caused by partial 
thrombosis of the right hepatic artery asso-
ciated with right portal branch thrombosis 
was found in one of the 50 patients (2%). 
No patient had intrahepatic bile duct dilata-
tion. Pneumobilia was detected in eight of 50 
patients (16%); pneumoperitoneum in seven 
(14%); ascites in 22 (44%); periportal lym-
phedema in five (10%); pleural effusion or 
pulmonary atelectasia in 43 (86%); associat-
ed pleural and pulmonary involvement in 39 
(78%); and pleural effusion or pulmonary at-
electasia alone in two patients each (4%).
Discussion
We found a pancreatic fistula in 54% of 
our patients, a higher percentage than report-
ed by others [4, 8, 13]. Likely explanations 
for the high incidence of pancreatic fistula in 
our study are, first, a definition of pancreatic 
fistula that relies not only on imaging find-
ings but also on clinical and biologic data 
and, second, inclusion only of patients with a 
soft pancreas, a well-recognized risk factor 
for the development of pancreatic fistula [1, 
5, 7, 10, 15]. In the surgical literature, terms 
such as pancreatic leak, pancreatic leakage, 
and pancreatic fistula are used alternately 
[17]. We consider the last the most appropri-
ate for indicating failure of healing and seal-
ing of the pancreaticogastric or pancreati-
cojejunal anastomosis.
The diagnosis of pancreatic fistula classi-
cally has been based on clinicobiologic data. 
Using the definition proposed by the Inter-
national Study Group on Pancreatic Fistula 
[11], we made the diagnosis of pancreatic fis-
tula on postoperative day 7 in the cases of 
22 of the 27 patients (81%) with pancreatic 
fistula. This result confirms the high sensi-
tivity (70–75%) of clinical and biologic cri-
teria for the diagnosis of pancreatic fistu-
la reported in the literature [14, 16, 17]. CT 
performed on postoperative day 7 depicted 
a perianastomotic collection in 13 of our 22 
patients (59%) with overt pancreatic fistula. 
Although CT had no diagnostic influence in 
this group of patients, it nevertheless had an 
influence on therapy.
Despite our results, some occult pancreat-
ic fistulas are initially clinically silent [16]. 
These fistulas usually are diagnosed after the 
patient resumes oral intake or after hospital 
discharge and typically necessitate reoper-
ation or readmission for potentially lethal 
complications, such as arterial hemorrhage 
and sepsis [1, 5, 8, 20, 22]. These observa-
tions emphasize the importance of accurate 
screening for occult pancreatic fistula, par-
ticularly among patients at high risk. Five of 
the 50 patients (10%) in this study had a clin-
ically silent pancreatic fistula on postopera-
tive day 7. In these patients, CT revealed a 
perianastomotic collection suggestive of pan-
creatic fistula in four of five patients (80%). 
These results confirm that clinical and bio-
logic criteria alone are not sufficiently reli-
able in the immediately postoperative period 
and emphasize the added value of CT [16].
A potential limitation of CT is represent-
ed by false-positive diagnoses of pancreatic 
fistula. In this study, however, we found that 
true-positive and false-positive perianasto-
motic collections behaved differently. False-
positive perianastomotic collections were 
smaller (although not significantly); never 
contained air bubbles; and, most important, 
had disappeared at follow-up CT in all cases, 
Fig. 4—52-year-old man 7 days after 
pancreaticoduodenectomy for pseudotumoral 
cholangitis. Transverse contrast-enhanced 
helical CT scan of abdomen shows small fluid 
collection (arrows) without air bubbles very close to 
anastomosis. Both radiologists correctly identified 
small perianastomotic fluid collection and suspected 
presence of pancreatic fistula, but clinical and 
biologic findings were negative for pancreatic fistula 
on postoperative day 7 and at follow-up until hospital 
discharge. Collection was not present on CT scan 
obtained on postoperative day 14.
Fig. 5—82-year-old woman 7 days after 
pancreaticoduodenectomy for duodenal 
adenocarcinoma. Transverse contrast-enhanced 
helical CT scan of abdomen shows no perianastomotic 
fluid collection at anastomosis (white arrow). Drainage 
tube (arrowhead) is next to anastomosis. Black arrow 
indicates perivascular cuffing around celiac trunk. 
Patient had clinicobiologic diagnosis of pancreatic 
fistula on postoperative day 7. Both radiologists 
correctly identified lack of perianastomotic fluid 
collection. Drain output established diagnosis of 
pancreatic fistula.
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unlike perianastomotic collections due to fis-
tula. Because small collections can be diffi-
cult to aspirate, we propose considering pan-
creatic fistula present and maintaining total 
parenteral nutrition until perianastomotic 
collections resolve spontaneously.
One of the strengths of our study was that 
CT was performed on postoperative day 7 
for all patients. The interval between surgery 
and CT was based on observations that the 
diagnosis of pancreatic fistula is made an av-
erage of 7 days after pancreaticoduodenec-
tomy [5, 14, 15]. One study [26] showed that 
a fluid collection seen around the pancreati-
cojejunostomy site and in the pancreatic bed 
on CT images may be caused by pancreatic 
fistula in patients who have undergone pan-
creaticoduodenectomy. That study, however, 
was limited by selection bias: Only patients 
with clinically suspected complications were 
included. Moreover, the time between sur-
gery and CT was not uniform, ranging from 
4 to 30 days.
Another way to diagnose occult pancre-
atic fistula may be sinography–fistulogra-
phy. However, this technique is seldom used 
and not is recommended on a routine basis 
for the diagnosis of pancreatic fistula [5, 14, 
16, 27]. We did not perform sinography–fis-
tulography to confirm the diagnosis of pan-
creatic fistula because we believe, as do 
other authors [28], that the best way to di-
agnose pancreatic fistula is to closely moni-
tor the output of the drain in the pancreat-
ic bed. Furthermore, fistulography cannot be 
performed easily with the multichannel open 
drainage we used. Fistulography may be use-
ful only for planning stepwise mobilization 
of the drain from the anastomotic area in pa-
tients with prolonged placement of an exter-
nal fistula [17, 29].
CT proved useful in the detection of com-
plications such as portal venous thrombosis 
and liver complications [22, 30–32]. At CT, 
we found only one liver complication due to 
intrahepatic arterial and portal venous throm-
bosis. We also evaluated expected postoper-
ative changes that must be recognized and 
differentiated from recurrence of malig-
nant disease. We found perivascular cuffing 
of mesenteric, celiac, or hepatic vessels and 
reactive lymph nodes in 28% and 6% of pa-
tients, unlike Mortelé et al. [31], who found 
perivascular abnormalities and reactive lymph 
nodes in 60% and 32% of patients. A poten-
tial explanation for the difference in results 
may be that the interval between surgery and 
CT in the study by Mortelé et al. varied from 
13 days to 6 years. Periportal lymphedema 
has rarely been reported after pancreaticodu-
odenectomy [31]. This finding was observed 
in 10% of patients in our series and may be 
explained by early postoperative changes due 
to extensive lymphatic dissection.
Our study had limitations. First, to our 
knowledge, there is no consensus in the liter-
ature regarding the clinical and biologic crite-
ria for the diagnosis of pancreatic fistula [17]. 
Amylase level is unanimously considered 
the principal biologic criterion for a diagno-
sis of pancreatic fistula, although a reliable 
cutoff value for absolute amylase activity 
has not been established, to our knowledge. 
Drain amylase levels, volume of drain output, 
and timing of collection in the postoperative 
course differ considerably among authors [11, 
17, 13, 20, 33], and the incidence of pancreat-
ic fistula varies with the definitions used [17]. 
We adopted the internationally accepted and 
unifying International Study Group on Pan-
creatic Fistula criteria [11], which result in 
higher sensitivity for the detection of pancre-
atic fistula. Second, most of our patients un-
derwent pancreaticogastrostomy. Although 
pancreaticojejunostomy is generally used to 
reconstruct the digestive tract and remnant 
pancreas, pancreaticogastrostomy has been 
reintroduced because of the lower incidence 
of complications in comparison with pancre-
aticojejunostomy [34]. Third, we included 
only patients at high risk of pancreatic fistu-
la; therefore, spectrum bias might have been 
present. Fourth, we reviewed the CT images 
retrospectively, although all patients system-
atically underwent CT on postoperative day 
7, and CT analysis was made without clinical 
and biologic information.
We conclude that pancreatic fistula is a 
frequent complication after pancreaticoduo-
denectomy among patients with soft pancre-
as. In these patients, clinical and biologic cri-
teria remain the mainstay of diagnosis. The 
presence of a perianastomotic collection at 
CT on postoperative day 7 may be sugges-
tive of but is not conclusive for the diagnosis 
of pancreatic fistula. In patients at high risk 
of pancreatic fistula that initially is clinically 
silent and undetected on the basis of clinical 
and biologic criteria, CT may be proposed as 
a complementary diagnostic tool, particular-
ly for detection of clinically occult pancre-
atic fistula.
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